NO20022599L - Klorofyll- og bakterioklorofyllestere, deres fremstilling og farmasöytiske sammensetninger som innbefatter slike - Google Patents
Klorofyll- og bakterioklorofyllestere, deres fremstilling og farmasöytiske sammensetninger som innbefatter slikeInfo
- Publication number
- NO20022599L NO20022599L NO20022599A NO20022599A NO20022599L NO 20022599 L NO20022599 L NO 20022599L NO 20022599 A NO20022599 A NO 20022599A NO 20022599 A NO20022599 A NO 20022599A NO 20022599 L NO20022599 L NO 20022599L
- Authority
- NO
- Norway
- Prior art keywords
- sub
- sup
- coxr
- chlorophyll
- bacteriochlorophyll
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/10—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13325399A IL133253A0 (en) | 1999-12-01 | 1999-12-01 | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| PCT/IL2000/000811 WO2001040232A1 (en) | 1999-12-01 | 2000-12-01 | Chlorophyll and bacteriochlorophyll esters, and their preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20022599D0 NO20022599D0 (no) | 2002-05-31 |
| NO20022599L true NO20022599L (no) | 2002-07-11 |
| NO323208B1 NO323208B1 (no) | 2007-01-22 |
Family
ID=11073554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20022599A NO323208B1 (no) | 1999-12-01 | 2002-05-31 | Omforestringsfremgangsmate for fremstilling av klorofyll- og bakterioklorofyll-C13(3), C-17(3) diestere |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7169753B2 (no) |
| EP (1) | EP1246826B1 (no) |
| JP (1) | JP2003515538A (no) |
| CN (1) | CN1222526C (no) |
| AT (1) | ATE308545T1 (no) |
| AU (1) | AU777761B2 (no) |
| BR (1) | BR0016051A (no) |
| CA (1) | CA2392989A1 (no) |
| DE (1) | DE60023748T2 (no) |
| DK (1) | DK1246826T3 (no) |
| ES (1) | ES2250214T3 (no) |
| HU (1) | HU224553B1 (no) |
| IL (1) | IL133253A0 (no) |
| MX (1) | MXPA02005455A (no) |
| NO (1) | NO323208B1 (no) |
| PL (1) | PL356391A1 (no) |
| RU (1) | RU2250905C2 (no) |
| WO (1) | WO2001040232A1 (no) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9192780B2 (en) | 1998-11-30 | 2015-11-24 | L'oreal | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
| US6887260B1 (en) | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US20060212025A1 (en) | 1998-11-30 | 2006-09-21 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| EP1318807A4 (en) * | 2000-08-11 | 2008-02-20 | Ceramoptec Gmbh | LIGHT-SENSITIVE OINTMENT |
| CA2485224A1 (en) | 2002-05-08 | 2003-11-20 | Yeda Research And Development Co. Ltd. | Sensitized online bold-mri imaging method |
| IL152900A0 (en) | 2002-11-17 | 2003-06-24 | Yeda Res & Dev | Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses |
| EP1648385B1 (en) | 2003-07-31 | 2016-05-04 | Gentlewaves Llc | System and method for the photodynamic treatment of skin |
| CA2437638A1 (en) | 2003-08-20 | 2005-02-20 | John Robert North | Photodynamic therapy |
| CA2457214A1 (en) | 2004-02-06 | 2005-08-06 | Qlt Inc. | Photodynamic therapy for the treatment of acne |
| EP1753457B8 (en) * | 2004-06-07 | 2016-09-21 | Yeda Research And Development Co., Ltd. | Cationic bacteriochlorophyll derivatives and uses thereof |
| EP1755676B1 (en) | 2004-06-09 | 2012-11-28 | QLT, Inc. | Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied verteporfin and/or lemuteporfin |
| GB2415372A (en) * | 2004-06-23 | 2005-12-28 | Destiny Pharma Ltd | Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent |
| RU2303966C2 (ru) * | 2005-10-11 | 2007-08-10 | Федеральное Государственное Учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию | Способ снижения поверхностной дозы офтальмоаппликатора при проведении брахитерапии внутриглазных новообразований |
| RU2345803C2 (ru) * | 2006-11-30 | 2009-02-10 | Закрытое Акционерное Общество "Исследовательские лаборатории "РАДА-ФАРМА" | Способ фотоиммунотерапии фотосенсибилизатором, активируемым волновой энергией вне организма человека |
| RU2336917C1 (ru) * | 2007-05-29 | 2008-10-27 | Государственное образовательное учреждение дополнительного профессионального образования Российская медицинская академия последипломного образования Федерального агентства по здравоохранению и социальному развитию (ГОУДПО РМАПО Росздрава) | Способ лечения больных псориазом |
| US20090036952A1 (en) | 2007-07-30 | 2009-02-05 | National Yang-Ming University | Induction driven light module and use thereof |
| FR2924021B1 (fr) * | 2007-11-27 | 2010-08-13 | Du Vernet Michele Eymard | Composition pour le traitement de la peau par therapie photodynamique |
| US20110040170A1 (en) * | 2008-01-28 | 2011-02-17 | Yeda Research And Development Co., Ltd. | Endoscopic imaging photodynamic therapy system and methods of use |
| PT2257309T (pt) | 2008-02-27 | 2020-01-22 | Yeda Res And Development Company Ltd | Conjugados rgd-(bacterio)clorofila para utilização no diagnóstico de tumores compreendendo domínios necróticos |
| CA2824768A1 (en) | 2011-01-13 | 2012-07-19 | Qlt Inc. | Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof |
| ES2856698T3 (es) * | 2011-08-23 | 2021-09-28 | Yeda Res & Dev | Fotosensibilizadores de (bacterio)clorofila para el tratamiento de enfermedades y trastornos oculares |
| WO2014011875A1 (en) | 2012-07-11 | 2014-01-16 | Dermira, Inc. | Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof |
| WO2015006429A1 (en) | 2013-07-12 | 2015-01-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery |
| SG11201808849TA (en) * | 2016-04-10 | 2018-11-29 | Yeda Res & Dev | Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative |
| CN108341827A (zh) * | 2018-02-02 | 2018-07-31 | 浙江海正药业股份有限公司 | 一种制备脱镁细菌叶绿素a及脱镁细菌叶绿素a酯的方法 |
| CN108191877A (zh) * | 2018-02-05 | 2018-06-22 | 云南瑞宝生物科技股份有限公司 | 一种从蚕沙中提取和纯化叶绿素的方法 |
| WO2020014522A1 (en) | 2018-07-12 | 2020-01-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Binary lipid bilayer-containing vesicles comprising embedded cytotoxic agents and methods of making and using the same |
| CN111171030B (zh) * | 2018-11-12 | 2022-11-22 | 浙江海正药业股份有限公司 | 细菌叶绿素衍生物及其制备方法 |
| CN111848656B (zh) * | 2020-06-24 | 2023-03-14 | 天津大学 | 离子修饰的原卟啉镓化合物及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU857139A1 (ru) * | 1979-11-02 | 1981-08-23 | Предприятие П/Я В-2343 | Способ получени порфиринов,содержащих изоциклическое метилциклопентановое кольцо |
| US5171741A (en) * | 1989-04-21 | 1992-12-15 | Health Research, Inc. | Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
| DE4121876A1 (de) * | 1991-07-02 | 1993-01-14 | Scheer Hugo | Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung |
| DE4121867A1 (de) | 1991-07-02 | 1993-01-07 | Leifeld & Lemke Maschf | Vorrichtung zur pruefung der dichtigkeit von mit deckeln luftdicht verschlossenen bechern |
| IL102645A (en) * | 1992-07-26 | 1998-02-22 | Yeda Res & Dev | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| IL116126A0 (en) * | 1995-11-24 | 1996-01-31 | Yeda Res & Dev | Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them |
-
1999
- 1999-12-01 IL IL13325399A patent/IL133253A0/xx unknown
-
2000
- 2000-12-01 JP JP2001540987A patent/JP2003515538A/ja not_active Abandoned
- 2000-12-01 HU HU0204167A patent/HU224553B1/hu not_active IP Right Cessation
- 2000-12-01 AU AU17292/01A patent/AU777761B2/en not_active Ceased
- 2000-12-01 MX MXPA02005455A patent/MXPA02005455A/es active IP Right Grant
- 2000-12-01 BR BR0016051-2A patent/BR0016051A/pt not_active Application Discontinuation
- 2000-12-01 AT AT00979916T patent/ATE308545T1/de not_active IP Right Cessation
- 2000-12-01 CN CNB008186030A patent/CN1222526C/zh not_active Expired - Fee Related
- 2000-12-01 DK DK00979916T patent/DK1246826T3/da active
- 2000-12-01 PL PL00356391A patent/PL356391A1/xx not_active Application Discontinuation
- 2000-12-01 DE DE60023748T patent/DE60023748T2/de not_active Expired - Fee Related
- 2000-12-01 ES ES00979916T patent/ES2250214T3/es not_active Expired - Lifetime
- 2000-12-01 WO PCT/IL2000/000811 patent/WO2001040232A1/en not_active Ceased
- 2000-12-01 EP EP00979916A patent/EP1246826B1/en not_active Expired - Lifetime
- 2000-12-01 RU RU2002117287/04A patent/RU2250905C2/ru not_active IP Right Cessation
- 2000-12-01 US US10/148,552 patent/US7169753B2/en not_active Expired - Fee Related
- 2000-12-01 CA CA002392989A patent/CA2392989A1/en not_active Abandoned
-
2002
- 2002-05-31 NO NO20022599A patent/NO323208B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1425015A (zh) | 2003-06-18 |
| ES2250214T3 (es) | 2006-04-16 |
| EP1246826B1 (en) | 2005-11-02 |
| DE60023748D1 (de) | 2005-12-08 |
| NO323208B1 (no) | 2007-01-22 |
| AU777761B2 (en) | 2004-10-28 |
| US20030148926A1 (en) | 2003-08-07 |
| IL133253A0 (en) | 2001-04-30 |
| US7169753B2 (en) | 2007-01-30 |
| HUP0204167A3 (en) | 2004-08-30 |
| WO2001040232A9 (en) | 2002-09-12 |
| MXPA02005455A (es) | 2002-11-29 |
| ATE308545T1 (de) | 2005-11-15 |
| PL356391A1 (pl) | 2004-06-28 |
| HK1056557A1 (en) | 2004-02-20 |
| WO2001040232A1 (en) | 2001-06-07 |
| RU2250905C2 (ru) | 2005-04-27 |
| CN1222526C (zh) | 2005-10-12 |
| HU224553B1 (hu) | 2005-10-28 |
| JP2003515538A (ja) | 2003-05-07 |
| AU1729201A (en) | 2001-06-12 |
| EP1246826A1 (en) | 2002-10-09 |
| DK1246826T3 (da) | 2006-01-02 |
| BR0016051A (pt) | 2002-07-23 |
| NO20022599D0 (no) | 2002-05-31 |
| HUP0204167A2 (hu) | 2003-03-28 |
| DE60023748T2 (de) | 2006-08-03 |
| CA2392989A1 (en) | 2001-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20022599D0 (no) | Klorofyll- og bakterioklorofyllesteres, deres fremstilling og farmasöytiske sammensetninger som innbefatter slike | |
| DE69835438T2 (de) | Photo-empfindlichkeit-erhöhende konjugate zur targeting von pathogene | |
| CY1121447T1 (el) | Συνθεσεις για αυξηση δραστηριοτητας τελομερασης | |
| ES2136673T3 (es) | Utilizacion del factor de crecimiento de los queratinocitos para la obtencion de medicamentos. | |
| GEP20022804B (en) | Erythropoietin Derivatives | |
| BR9507506A (pt) | Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico | |
| EP1226109A4 (en) | PHENYLAMINE CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DISPENSING ACTIVE AGENTS | |
| AU2021221865A1 (en) | Photosensitive dispersion and use thereof | |
| DK0661987T3 (da) | Morphogeninduceret leverregeneration | |
| RU94046426A (ru) | Фармацевтические композиции, способы лечения лейкоза, способ повышения уровней стволовых клеток, антагонист с - kit - лиганда, антисмысловая нуклеиновая кислота, способ лечения меланомы, способ усиления трансфекции, способ переноса гена, способ увеличения уровней периферической крови, способ повышения уровней тромбоцитов, способы модификации биологической функции, способ лечения анемии, способ улучшения приживления костного мозга, способ ускорения восстановления костного мозга, способ лечения лейкопении | |
| RU95110937A (ru) | Хинолоновые и акридиноновые соединения, способ их получения, фармацевтическая композиция и промежуточные соединения | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| ATE426402T1 (de) | Medizinische zusammensetzungen enthaltend 2-amino-2-a2-(4-octylphenyl)ethylupropan-1,3-di l | |
| DK1007566T3 (da) | Terapeutisk anvendelse af SMR1-protein og aktive derivater deraf | |
| ITRM970238A0 (it) | Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella terapia di patologie corneali e congiuntivali | |
| RU2007129266A (ru) | Фармацевтический состав для профилактики рака и для борьбы с ним | |
| DK1165102T3 (da) | Matrixproteinpræparater til podning i ikke-mineraliseret væv | |
| PT941110E (pt) | Utilizacao do factor 2 de crescimento dos ceratinocitos | |
| DK0588477T3 (da) | Medicinsk præparat omfatende TCF-11 | |
| AU2002333535A1 (en) | Treatment of excessive radiation (e.g. sunburn) exposure | |
| NO995692D0 (no) | Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse | |
| AU2018363797A1 (en) | Composition for the treatment of intracellular bacterial infection | |
| EP1361905B8 (en) | Matrix protein compositions for guided connective tissue growth | |
| BR0014751A (pt) | Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto | |
| CY1108761T1 (el) | Απενεργοποιημενες κυτοκινες για ανοσοποιηση |